Clinical Trials Browser

Phase 1/2 × Recruiting × Radiation Dose Hypofractionation × Clear all

NCT04172532 2026-03-18

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Phase 1/2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04683653 2025-12-29

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Phase 1/2 Recruiting

Endometrial Neoplasms

NCT04636008 2024-08-06

Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer

Phase 1/2 Recruiting

Gastrointestinal

Turcot syndrome, Rectal Neoplasms